insights_auto
Why is MMQ0 down 3.76%?
Dive Deeperchevron_right
MMQ0:FRA
Definium Therapeutics Inc
€30.70
arrow_downward
-3.76%(-1.20) 1D
Oct 13, 11:46:17 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MMQ0...
Open
€30.60
High
€30.70
Low
€30.60
Mkt. cap
4.62B
Avg. vol.
37.00
Volume
0.00
52-wk high
€42.70
52-wk low
€12.81
No. of employees
106
Open
€30.60
High
€30.70
Low
€30.60
Mkt. cap
4.62B
Avg. vol.
37.00
Volume
0.00
52-wk high
€42.70
52-wk low
€12.81
No. of employees
106
News stories
From web sources and news partners
Benzinga
·
55 minutes ago
VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at Worl
Stock Titan
·
1 hour ago
Nasdaq files to remove Bone Biologics (Nasdaq: BBLG) warrants from listing and/or registration.
Yahoo Finance
·
35 minutes ago
XRP Fell 8% in the Week It Got a Nasdaq Listing, a Dubai Bank Deal and an ETF Inflow. Why Did None of It Count?
CNBC
·
1 hour ago
Opening Bell: October 13 2026
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com